260 related articles for article (PubMed ID: 12835306)
1. Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy.
Sebire NJ; Haselden S; Malone M; Davies EG; Ramsay AD
J Clin Pathol; 2003 Jul; 56(7):555-7. PubMed ID: 12835306
[TBL] [Abstract][Full Text] [Related]
2. Posttransplantation lymphoproliferative disease with features of lymphomatoid granulomatosis in a lung transplant patient.
Kwon EJ; Katz KA; Draft KS; Seykora JT; Rook AH; Wasik MA; Junkins-Hopkins JM
J Am Acad Dermatol; 2006 Apr; 54(4):657-63. PubMed ID: 16546589
[TBL] [Abstract][Full Text] [Related]
3. Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder.
Melani C; Jaffe ES; Wilson WH
Blood; 2020 Apr; 135(16):1344-1352. PubMed ID: 32107539
[TBL] [Abstract][Full Text] [Related]
4. An eschar and violaceous nodules as the presenting signs of lymphomatoid granulomatosis.
Fischer R; Shaath T; Meade C; Fraga GR; Rajpara A
Dermatol Online J; 2014 Nov; 20(11):. PubMed ID: 25419752
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features.
Beaty MW; Toro J; Sorbara L; Stern JB; Pittaluga S; Raffeld M; Wilson WH; Jaffe ES
Am J Surg Pathol; 2001 Sep; 25(9):1111-20. PubMed ID: 11688570
[TBL] [Abstract][Full Text] [Related]
6. Chronic lymphocytic infiltration with pontine perivascular enhancement responsive to steroids (CLIPPERS) and its association with Epstein-Barr Virus (EBV)-related lymphomatoid granulomatosis: a case report.
Dang YL; Kok HK; McKelvie PA; Ligtermoet M; Maddy L; Burrows DA; Crompton DE
BMC Neurol; 2021 Feb; 21(1):80. PubMed ID: 33602163
[TBL] [Abstract][Full Text] [Related]
7. Rapidly progressive Epstein-Barr virus-associated lymphoproliferative disorder unpredictable by weekly viral load monitoring.
Wakabayashi S; Ohashi K; Hanajiri R; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
Intern Med; 2010; 49(10):931-5. PubMed ID: 20467179
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and pathological features of 13 children with Epstein-Barr virus-positive lymphoproliferative disease].
Chen TM; Deng ZJ; Hu B; Hu HL; Chen HY; Li SY; Liu G
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):759-764. PubMed ID: 30293280
[No Abstract] [Full Text] [Related]
9. Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b.
Wilson WH; Kingma DW; Raffeld M; Wittes RE; Jaffe ES
Blood; 1996 Jun; 87(11):4531-7. PubMed ID: 8639820
[TBL] [Abstract][Full Text] [Related]
10. Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis.
Kameda H; Okuyama A; Tamaru J; Itoyama S; Iizuka A; Takeuchi T
Clin Rheumatol; 2007 Sep; 26(9):1585-9. PubMed ID: 17200802
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation.
Shaffer DR; Rooney CM; Gottschalk S
Immunotherapy; 2010 Sep; 2(5):663-71. PubMed ID: 20874650
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus-associated Lymphoproliferative Disorders in the Skin.
Goodlad JR
Surg Pathol Clin; 2017 Jun; 10(2):429-453. PubMed ID: 28477890
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of lymphoproliferative disease complicating primary immunodeficiency/immunodysregulatory disorders with reduced-intensity allogeneic stem-cell transplantation.
Cohen JM; Sebire NJ; Harvey J; Gaspar HB; Cathy C; Jones A; Rao K; Cubitt D; Amrolia PJ; Davies EG; Veys P
Blood; 2007 Sep; 110(6):2209-14. PubMed ID: 17502458
[TBL] [Abstract][Full Text] [Related]
14. Lymphomatoid granulomatosis of the skin and lung. An angiocentric T-cell-rich B-cell lymphoproliferative disorder.
McNiff JM; Cooper D; Howe G; Crotty PL; Tallini G; Crouch J; Eisen RN
Arch Dermatol; 1996 Dec; 132(12):1464-70. PubMed ID: 8961876
[TBL] [Abstract][Full Text] [Related]
15. A case of central nervous system lesion pathologically characterized by angiocentric, T-cell-rich lymphoid cell infiltrates: a case report and literature review.
Imai R; Tsujikawa H; Fukumura M; Sasaki A; Tsuda N; Kameyama K; Yoshida K; Sasaki H
Brain Tumor Pathol; 2021 Jul; 38(3):263-270. PubMed ID: 33783654
[TBL] [Abstract][Full Text] [Related]
16. A case of pulmonary lymphomatoid granulomatosis successfully treated by combination chemotherapy with rituximab.
Jung KH; Sung HJ; Lee JH; Lee KY; Shin JS; Kim KM; Kim YS; Shin C; Kim JH
Chemotherapy; 2009; 55(5):386-90. PubMed ID: 19752554
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary angiitis with atypical lymphoreticular infiltrates in Wiskott-Aldrich syndrome: possible relationship of lymphomatoid granulomatosis and EBV infection.
Ilowite NT; Fligner CL; Ochs HD; Brichacek B; Harada S; Haas JE; Purtilo DT; Wedgwood RJ
Clin Immunol Immunopathol; 1986 Dec; 41(3):479-84. PubMed ID: 3022973
[TBL] [Abstract][Full Text] [Related]
18. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases.
Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S
Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262
[TBL] [Abstract][Full Text] [Related]
19. EBV-Negative Cutaneous Lymphomatoid Granulomatosis With Concomitant EBV-Positive Pulmonary Involvement: A Potential Diagnostic and Prognostic Pitfall.
Messana K; Marburger T; Bergfeld W
Am J Dermatopathol; 2015 Sep; 37(9):707-11. PubMed ID: 25148107
[TBL] [Abstract][Full Text] [Related]
20. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
